Cargando…

Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma

Detalles Bibliográficos
Autores principales: Richardson, P. G., Hofmeister, C. C., Raje, N. S., Siegel, D. S., Lonial, S., Laubach, J., Efebera, Y. A., Vesole, D. H., Nooka, A. K., Rosenblatt, J., Doss, D., Zaki, M. H., Bensmaine, A., Herring, J., Li, Y., Watkins, L., Chen, M. S., Anderson, K. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887838/
https://www.ncbi.nlm.nih.gov/pubmed/30218008
http://dx.doi.org/10.1038/s41375-018-0235-5
_version_ 1783475100969861120
author Richardson, P. G.
Hofmeister, C. C.
Raje, N. S.
Siegel, D. S.
Lonial, S.
Laubach, J.
Efebera, Y. A.
Vesole, D. H.
Nooka, A. K.
Rosenblatt, J.
Doss, D.
Zaki, M. H.
Bensmaine, A.
Herring, J.
Li, Y.
Watkins, L.
Chen, M. S.
Anderson, K. C.
author_facet Richardson, P. G.
Hofmeister, C. C.
Raje, N. S.
Siegel, D. S.
Lonial, S.
Laubach, J.
Efebera, Y. A.
Vesole, D. H.
Nooka, A. K.
Rosenblatt, J.
Doss, D.
Zaki, M. H.
Bensmaine, A.
Herring, J.
Li, Y.
Watkins, L.
Chen, M. S.
Anderson, K. C.
author_sort Richardson, P. G.
collection PubMed
description
format Online
Article
Text
id pubmed-6887838
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68878382019-12-05 Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma Richardson, P. G. Hofmeister, C. C. Raje, N. S. Siegel, D. S. Lonial, S. Laubach, J. Efebera, Y. A. Vesole, D. H. Nooka, A. K. Rosenblatt, J. Doss, D. Zaki, M. H. Bensmaine, A. Herring, J. Li, Y. Watkins, L. Chen, M. S. Anderson, K. C. Leukemia Correction Nature Publishing Group UK 2018-09-14 2018 /pmc/articles/PMC6887838/ /pubmed/30218008 http://dx.doi.org/10.1038/s41375-018-0235-5 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Richardson, P. G.
Hofmeister, C. C.
Raje, N. S.
Siegel, D. S.
Lonial, S.
Laubach, J.
Efebera, Y. A.
Vesole, D. H.
Nooka, A. K.
Rosenblatt, J.
Doss, D.
Zaki, M. H.
Bensmaine, A.
Herring, J.
Li, Y.
Watkins, L.
Chen, M. S.
Anderson, K. C.
Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
title Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
title_full Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
title_fullStr Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
title_full_unstemmed Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
title_short Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
title_sort correction: pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887838/
https://www.ncbi.nlm.nih.gov/pubmed/30218008
http://dx.doi.org/10.1038/s41375-018-0235-5
work_keys_str_mv AT richardsonpg correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT hofmeistercc correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT rajens correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT siegelds correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT lonials correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT laubachj correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT efeberaya correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT vesoledh correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT nookaak correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT rosenblattj correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT dossd correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT zakimh correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT bensmainea correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT herringj correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT liy correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT watkinsl correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT chenms correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma
AT andersonkc correctionpomalidomidebortezomibandlowdosedexamethasoneinlenalidomiderefractoryandproteasomeinhibitorexposedmyeloma